AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Crow, DW Marsella, R Nicklin, CF
Citation: Dw. Crow et al., Double-blinded, placebo-controlled, cross-over pilot study on the efficacyof zileuton for canine atopic dermatitis, VET DERMATO, 12(4), 2001, pp. 189-195

Authors: Marsella, R Nicklin, CF
Citation: R. Marsella et Cf. Nicklin, Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis, VET DERMATO, 12(3), 2001, pp. 149-154

Authors: Marsella, R
Citation: R. Marsella, Update on the role of leukotrienes in the pathogenesis of atopy: a comparative review, VET DERMATO, 12(2), 2001, pp. 63-74

Authors: Marsella, R Nicklin, CF
Citation: R. Marsella et Cf. Nicklin, Sulphido-leukotriene production from peripheral leukocytes and skin in clinically normal dogs and house dust mite positive atopic dogs, VET DERMATO, 12(1), 2001, pp. 3-12

Authors: Marsella, R
Citation: R. Marsella, Managing dogs with chronic atopic dermatitis, COMP CONT E, 23(5), 2001, pp. 454

Authors: Olivry, T DeBoer, DJ Griffin, CE Halliwell, REW Hill, PB Hillier, A Marsella, R Sousa, CA
Citation: T. Olivry et al., The ACVD task force on canine atopic dermatitis: forewords and lexicon, VET IMMUNOL, 81(3-4), 2001, pp. 143-146

Authors: Sousa, CA Marsella, R
Citation: Ca. Sousa et R. Marsella, The ACVD task force on canine atopic dermatitis (II): genetic factors, VET IMMUNOL, 81(3-4), 2001, pp. 153-157

Authors: Marsella, R Olivry, T
Citation: R. Marsella et T. Olivry, The ACVD task force on canine atopic dermatitis (VII): mediators of cutaneous inflammation, VET IMMUNOL, 81(3-4), 2001, pp. 205-213

Authors: DeBoer, DJ Marsella, R
Citation: Dj. Deboer et R. Marsella, The ACVD task force on canine atopic dermatitis (XII): the relationship ofcutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis, VET IMMUNOL, 81(3-4), 2001, pp. 239-249

Authors: Marsella, R Sousa, CA
Citation: R. Marsella et Ca. Sousa, The ACVD task force on canine atopic dermatitis (XIII): threshold phenomenon and summation of effects, VET IMMUNOL, 81(3-4), 2001, pp. 251-253

Authors: Marsella, R Olivry, T
Citation: R. Marsella et T. Olivry, The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy, VET IMMUNOL, 81(3-4), 2001, pp. 331-345

Authors: Olivry, T Marsella, R Hillier, A
Citation: T. Olivry et al., The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?, VET IMMUNOL, 81(3-4), 2001, pp. 347-362

Authors: Marsella, R Nicklin, CF
Citation: R. Marsella et Cf. Nicklin, Double-blinded cross-over study on the efficacy of pentoxifylline for canine atopy, VET DERMATO, 11(4), 2000, pp. 255-260

Authors: Marsella, R
Citation: R. Marsella, Canine pemphigus complex: Diagnosis and therapy, COMP CONT E, 22(7), 2000, pp. 680

Authors: Marsella, R
Citation: R. Marsella, Canine pemphigus complex: Pathogenesis and clinical presentation, COMP CONT E, 22(6), 2000, pp. 568-572

Authors: Marsella, R Nicklin, CF Munson, JW Roberts, SM
Citation: R. Marsella et al., Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration, AM J VET RE, 61(6), 2000, pp. 631-637

Authors: Marsella, R
Citation: R. Marsella, Advances in flea control, VET CLIN SM, 29(6), 1999, pp. 1407

Authors: Marsella, R de Gopegui, RR
Citation: R. Marsella et Rr. De Gopegui, Leishmaniasis: a re-emerging zoonosis, INT J DERM, 37(11), 1998, pp. 801-814
Risultati: 1-18 |